4-methoxyamphetamine has been researched along with Immunoglobulin Light-chain Amyloidosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adler, ED; Ajmera, V; Asimakopoulos, F; Barman, P; Berumen, J; Bower, R; Brubaker, AL; Costello, C; Kearns, M; Khan, A; Kono, Y; Parekh, JR; Pretorius, V; Sanchez, R; Schnickel, GT; Shah, M; Silva Enciso, J; Taj, R; Tran, H; Urey, MA | 1 |
DRAPIEWSKI, JF; JONES, R; STERNLIEB, SB | 1 |
2 other study(ies) available for 4-methoxyamphetamine and Immunoglobulin Light-chain Amyloidosis
Article | Year |
---|---|
Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-in-world experience.
Topics: Adult; Death; Humans; Immunoglobulin Light-chain Amyloidosis; Kidney Transplantation; Liver; Male; Organ Preservation; Perfusion; Tissue and Organ Procurement; Tissue Donors | 2023 |
Primary amyloidosis with spontaneous rupture of the spleen and sudden death.
Topics: Amyloidosis; Death; Death, Sudden; Humans; Immunoglobulin Light-chain Amyloidosis; Rupture; Rupture, Spontaneous; Spleen; Splenic Rupture | 1955 |